Improving In Vivo Models for Preclinical Drug Development

Effective preclinical drug development hinges on the deployment of robust in vivo models that accurately recapitulate human disease and response to therapy. Optimizing these models involves a multifaceted approach, encompassing careful assessment of species determination, genetic background, disease manifestation, and experimental paradigm. Moreove

read more